GlassScriptPhysician profile
Erin Eileen Rivera
NPI 1790893147
$3,658.24
in general payments reported to CMS, 2019-2025
8 companies · $843 in 2025
The $843 reported for 2025 was more than what 86% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $1,096 · 2023: $676 · 2024: $934 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,297.92 | 2022-2025 | Rexulti, Abilify Maintena |
| Lundbeck LLC | $632.33 | 2021-2025 | Rexulti, Abilify Maintena |
| Alkermes, INC. | $491.70 | 2022-2024 | Lybalvi, Aristada |
| E.R. Squibb & Sons, L.L.C. | $454.32 | 2024-2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $415.19 | 2022-2024 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $206.68 | 2022-2024 | Austedo Xr |
| Jazz Pharmaceuticals INC. | $143.36 | 2025 | |
| W. L. Gore & Associates, INC. | $16.74 | 2025 | Gore Cardioform Septal Occluder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.